Objective:To explore the survival and prognostic factors of a long-course venetoclax-based(VEN-based)regimen in patients with de novo acute myeloid leukemia(AML)and provide evidence for the maintenance treatment of AML.Methods:A retrospective study was conducted in patients who received a VEN-based regimen and completed at least four courses of efficacy evaluation at The First Affiliated Hospital of Nanchang University from May 2021 to January 2024.The composite complete response rate(cCR),minimal residual disease(MRD)-negative rate,overall survival(OS)time,relapse-free survival(RFS)time,and adverse events were analyzed.Results:Overall,30 newly diagnosed patients with AML were enrolled in this study.The median age was 65(range,53-78)years,and the median number of treat-ment cycles was 7(range,4-20)years.After one cycle,the CR-and MRD-negative rates were 80.0%and 63.3%,respectively.The cumulative cCR was 96.7%,and MRD negative rate was 80.0%,respectively.The median follow-up time was 21.3(95%confidence intervals 14.7-27.9)months.The median OS time was 32.3 months and RFS time was not reached.The 2-year OS and RFS rates were 70.6%and 54.8%,respect-ively.Univariate analysis suggested that ELN2017 risk stratification and relapse status affected RFS and OS(P<0.05).However,the multivari-ate analysis failed to reveal any relationship between these factors and survival(P>0.05).In terms of safety,hematological adverse events were the most common,followed by infections.Overall,the VEN-based regimen was tolerated for patients with AML.Conclusions:A long-course VEN-based regimen is effective and safe.More than half of patients survive for>2 years,and it can be used as an effective mainten-ance treatment option for patients with AML.

The advent of new media technologies has fundamentally transformed professional ethics development in public hospitals,offering unprecedented opportunities through their real-time communication capabilities,interactive features,and ex-tensive reach.These technological advancements have remarkably improved medical ethics education outcomes,diversified public oversight mechanisms,and enhanced public sentiment management.Concurrently,they have introduced complex challenges,in-cluding information inaccuracy and professional ethics dilution,necessitating robust responses from healthcare institutions in digit-al infrastructure development and public opinion management.This article provides a comprehensive and in-depth research per-spective on the construction of professional ethics in public hospitals in the new era through a combination of theoretical analysis and practical exploration.To address these issues,this article proposes practical paths such as building an intelligent public opin-ion supervision system,modernizing traditional medical ethics culture,establishing an evaluation system for medical ethics that integrates new media technology,and innovating clean governance warning education.The study highlights the critical role of public participation,recommending the development of an open and transparent interactive mechanism through new media plat-forms.This approach aims to foster a comprehensive,multi-level ecosystem for the construction of professional ethics,offering in-sights into improving doctor-patient relationships and enhancing medical service quality,while also contributing to the high-quality development of the healthcare sector.In the future,we should further explore the deep integration of new media technology and the construction of professional ethics to build a more systematic and intelligent management system to meet the development needs of the digital age.

The advent of new media technologies has fundamentally transformed professional ethics development in public hospitals,offering unprecedented opportunities through their real-time communication capabilities,interactive features,and ex-tensive reach.These technological advancements have remarkably improved medical ethics education outcomes,diversified public oversight mechanisms,and enhanced public sentiment management.Concurrently,they have introduced complex challenges,in-cluding information inaccuracy and professional ethics dilution,necessitating robust responses from healthcare institutions in digit-al infrastructure development and public opinion management.This article provides a comprehensive and in-depth research per-spective on the construction of professional ethics in public hospitals in the new era through a combination of theoretical analysis and practical exploration.To address these issues,this article proposes practical paths such as building an intelligent public opin-ion supervision system,modernizing traditional medical ethics culture,establishing an evaluation system for medical ethics that integrates new media technology,and innovating clean governance warning education.The study highlights the critical role of public participation,recommending the development of an open and transparent interactive mechanism through new media plat-forms.This approach aims to foster a comprehensive,multi-level ecosystem for the construction of professional ethics,offering in-sights into improving doctor-patient relationships and enhancing medical service quality,while also contributing to the high-quality development of the healthcare sector.In the future,we should further explore the deep integration of new media technology and the construction of professional ethics to build a more systematic and intelligent management system to meet the development needs of the digital age.

Objective:To explore the survival and prognostic factors of a long-course venetoclax-based(VEN-based)regimen in patients with de novo acute myeloid leukemia(AML)and provide evidence for the maintenance treatment of AML.Methods:A retrospective study was conducted in patients who received a VEN-based regimen and completed at least four courses of efficacy evaluation at The First Affiliated Hospital of Nanchang University from May 2021 to January 2024.The composite complete response rate(cCR),minimal residual disease(MRD)-negative rate,overall survival(OS)time,relapse-free survival(RFS)time,and adverse events were analyzed.Results:Overall,30 newly diagnosed patients with AML were enrolled in this study.The median age was 65(range,53-78)years,and the median number of treat-ment cycles was 7(range,4-20)years.After one cycle,the CR-and MRD-negative rates were 80.0%and 63.3%,respectively.The cumulative cCR was 96.7%,and MRD negative rate was 80.0%,respectively.The median follow-up time was 21.3(95%confidence intervals 14.7-27.9)months.The median OS time was 32.3 months and RFS time was not reached.The 2-year OS and RFS rates were 70.6%and 54.8%,respect-ively.Univariate analysis suggested that ELN2017 risk stratification and relapse status affected RFS and OS(P<0.05).However,the multivari-ate analysis failed to reveal any relationship between these factors and survival(P>0.05).In terms of safety,hematological adverse events were the most common,followed by infections.Overall,the VEN-based regimen was tolerated for patients with AML.Conclusions:A long-course VEN-based regimen is effective and safe.More than half of patients survive for>2 years,and it can be used as an effective mainten-ance treatment option for patients with AML.

Proteins in the human body are usually made of 20 natural amino acids.Through different amino acid combinations and isomerization, proteins of diverse functions are built.An emerging genetic code expansion technology can introduce unnatural amino acids into specific sites of target protein, endowing the protein with new biological characteristics including covalently binding with proximal proteins, carrying fluorescence, and mimicking specific protein post-translational modifications.In this paper, based on the structure and function of unnatural amino acids, the applications of different types of unnatural amino acids in regulating protein''s stability, studying protein''s conformation, expression level, and localization, and uncovering heretofore unknown protein-protein interactions were reviewed.Besides, genetic code expansion of unnatural amino acids is anticipated to find broad utilities in biomedicine by bringing new ideas and methods to the design and optimization of biologics.